| Item | Property | Value | Comments | 
|---|
|  include | http://hl7.org/fhir/sid/cvx |  |  | 
|   Concept | 01 | diphtheria, tetanus toxoids and pertussis vaccine |  | 
|   Concept | 02 | trivalent poliovirus vaccine, live, oral |  | 
|   Concept | 03 | measles, mumps and rubella virus vaccine |  | 
|   Concept | 04 | measles and rubella virus vaccine |  | 
|   Concept | 05 | measles virus vaccine |  | 
|   Concept | 06 | rubella virus vaccine |  | 
|   Concept | 07 | mumps virus vaccine |  | 
|   Concept | 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |  | 
|   Concept | 09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
|   Concept | 10 | poliovirus vaccine, inactivated |  | 
|   Concept | 100 | pneumococcal conjugate vaccine, 7 valent |  | 
|   Concept | 101 | typhoid Vi capsular polysaccharide vaccine |  | 
|   Concept | 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |  | 
|   Concept | 103 | meningococcal C conjugate vaccine |  | 
|   Concept | 104 | hepatitis A and hepatitis B vaccine |  | 
|   Concept | 105 | vaccinia (smallpox) vaccine, diluted |  | 
|   Concept | 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |  | 
|   Concept | 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |  | 
|   Concept | 108 | meningococcal ACWY vaccine, unspecified formulation |  | 
|   Concept | 109 | pneumococcal vaccine, unspecified formulation |  | 
|   Concept | 11 | pertussis vaccine |  | 
|   Concept | 110 | DTaP-hepatitis B and poliovirus vaccine |  | 
|   Concept | 111 | influenza virus vaccine, live, attenuated, for intranasal use |  | 
|   Concept | 112 | tetanus toxoid, unspecified formulation |  | 
|   Concept | 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
|   Concept | 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |  | 
|   Concept | 115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |  | 
|   Concept | 116 | rotavirus, live, pentavalent vaccine |  | 
|   Concept | 117 | varicella zoster immune globulin (Investigational New Drug) |  | 
|   Concept | 118 | human papilloma virus vaccine, bivalent |  | 
|   Concept | 119 | rotavirus, live, monovalent vaccine |  | 
|   Concept | 12 | diphtheria antitoxin |  | 
|   Concept | 120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
|   Concept | 121 | zoster vaccine, live |  | 
|   Concept | 122 | rotavirus vaccine, unspecified formulation |  | 
|   Concept | 123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |  | 
|   Concept | 125 | Novel Influenza-H1N1-09, live virus for nasal administration |  | 
|   Concept | 126 | Novel influenza-H1N1-09, preservative-free, injectable |  | 
|   Concept | 127 | Novel influenza-H1N1-09, injectable |  | 
|   Concept | 128 | Novel influenza-H1N1-09, all formulations |  | 
|   Concept | 129 | Japanese Encephalitis vaccine, unspecified formulation |  | 
|   Concept | 13 | tetanus immune globulin |  | 
|   Concept | 130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |  | 
|   Concept | 131 | Historical record of a typhus vaccination |  | 
|   Concept | 132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |  | 
|   Concept | 133 | pneumococcal conjugate vaccine, 13 valent |  | 
|   Concept | 134 | Japanese Encephalitis vaccine for intramuscular administration |  | 
|   Concept | 135 | influenza, high dose seasonal, preservative-free |  | 
|   Concept | 136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |  | 
|   Concept | 137 | HPV, unspecified formulation |  | 
|   Concept | 138 | tetanus and diphtheria toxoids, not adsorbed, for adult use |  | 
|   Concept | 139 | Td(adult) unspecified formulation |  | 
|   Concept | 14 | immune globulin, unspecified formulation |  | 
|   Concept | 140 | Influenza, seasonal, injectable, preservative free |  | 
|   Concept | 141 | Influenza, seasonal, injectable |  | 
|   Concept | 142 | tetanus toxoid, not adsorbed |  | 
|   Concept | 143 | Adenovirus, type 4 and type 7, live, oral |  | 
|   Concept | 144 | seasonal influenza, intradermal, preservative free |  | 
|   Concept | 147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |  | 
|   Concept | 148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |  | 
|   Concept | 149 | influenza, live, intranasal, quadrivalent |  | 
|   Concept | 15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |  | 
|   Concept | 150 | Influenza, injectable, quadrivalent, preservative free |  | 
|   Concept | 151 | influenza nasal, unspecified formulation |  | 
|   Concept | 152 | Pneumococcal Conjugate, unspecified formulation |  | 
|   Concept | 153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free |  | 
|   Concept | 155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |  | 
|   Concept | 156 | Rho(D) Immune globulin- IV or IM |  | 
|   Concept | 157 | Rho(D) Immune globulin - IM |  | 
|   Concept | 158 | influenza, injectable, quadrivalent, contains preservative |  | 
|   Concept | 159 | Rho(D) Unspecified formulation |  | 
|   Concept | 16 | influenza virus vaccine, whole virus |  | 
|   Concept | 160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |  | 
|   Concept | 161 | Influenza, injectable,quadrivalent, preservative free, pediatric |  | 
|   Concept | 162 | meningococcal B vaccine, fully recombinant |  | 
|   Concept | 163 | meningococcal B vaccine, recombinant, OMV, adjuvanted |  | 
|   Concept | 164 | meningococcal B, unspecified formulation |  | 
|   Concept | 165 | Human Papillomavirus 9-valent vaccine |  | 
|   Concept | 166 | influenza, intradermal, quadrivalent, preservative free, injectable |  | 
|   Concept | 167 | meningococcal vaccine of unknown formulation and unknown serogroups |  | 
|   Concept | 168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |  | 
|   Concept | 169 | Hep A, live attenuated-IM |  | 
|   Concept | 17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |  | 
|   Concept | 170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
|   Concept | 171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |  | 
|   Concept | 172 | cholera, WC-rBS |  | 
|   Concept | 173 | cholera, BivWC |  | 
|   Concept | 174 | cholera, live attenuated |  | 
|   Concept | 175 | Human Rabies vaccine from human diploid cell culture |  | 
|   Concept | 176 | Human rabies vaccine from Chicken fibroblast culture |  | 
|   Concept | 177 | pneumococcal conjugate vaccine, 10 valent |  | 
|   Concept | 178 | Non-US bivalent oral polio vaccine (types 1 and 3) |  | 
|   Concept | 179 | Non-US monovalent oral polio vaccine, unspecified formulation |  | 
|   Concept | 18 | rabies vaccine, for intramuscular injection RETIRED CODE |  | 
|   Concept | 180 | tetanus immune globulin |  | 
|   Concept | 181 | anthrax immune globulin |  | 
|   Concept | 182 | Oral Polio Vaccine, Unspecified formulation |  | 
|   Concept | 183 | Yellow fever vaccine alternative formulation |  | 
|   Concept | 184 | Yellow fever vaccine, unspecified formulation |  | 
|   Concept | 185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |  | 
|   Concept | 186 | Influenza, injectable, Madin Darby Canine Kidney,  quadrivalent with preservative |  | 
|   Concept | 187 | zoster vaccine recombinant |  | 
|   Concept | 188 | zoster vaccine, unspecified formulation |  | 
|   Concept | 189 | Hepatitis B vaccine (recombinant), CpG adjuvanted |  | 
|   Concept | 19 | Bacillus Calmette-Guerin vaccine |  | 
|   Concept | 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine |  | 
|   Concept | 21 | varicella virus vaccine |  | 
|   Concept | 22 | DTP-Haemophilus influenzae type b conjugate vaccine |  | 
|   Concept | 23 | plague vaccine |  | 
|   Concept | 24 | anthrax vaccine |  | 
|   Concept | 25 | typhoid vaccine, live, oral |  | 
|   Concept | 26 | cholera vaccine, unspecified formulation |  | 
|   Concept | 27 | botulinum antitoxin |  | 
|   Concept | 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use |  | 
|   Concept | 29 | cytomegalovirus immune globulin, intravenous |  | 
|   Concept | 30 | hepatitis B immune globulin |  | 
|   Concept | 31 | hepatitis A vaccine, pediatric dosage, unspecified formulation |  | 
|   Concept | 32 | meningococcal polysaccharide vaccine (MPSV4) |  | 
|   Concept | 33 | pneumococcal polysaccharide vaccine, 23 valent |  | 
|   Concept | 34 | rabies immune globulin |  | 
|   Concept | 35 | tetanus toxoid, adsorbed |  | 
|   Concept | 36 | varicella zoster immune globulin |  | 
|   Concept | 37 | yellow fever vaccine |  | 
|   Concept | 38 | rubella and mumps virus vaccine |  | 
|   Concept | 39 | Japanese Encephalitis Vaccine SC |  | 
|   Concept | 40 | rabies vaccine, for intradermal injection |  | 
|   Concept | 41 | typhoid vaccine, parenteral, other than acetone-killed, dried |  | 
|   Concept | 42 | hepatitis B vaccine, adolescent/high risk infant dosage |  | 
|   Concept | 43 | hepatitis B vaccine, adult dosage |  | 
|   Concept | 44 | hepatitis B vaccine, dialysis patient dosage |  | 
|   Concept | 45 | hepatitis B vaccine, unspecified formulation |  | 
|   Concept | 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate |  | 
|   Concept | 47 | Haemophilus influenzae type b vaccine, HbOC conjugate |  | 
|   Concept | 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate |  | 
|   Concept | 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |  | 
|   Concept | 50 | DTaP-Haemophilus influenzae type b conjugate vaccine |  | 
|   Concept | 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |  | 
|   Concept | 52 | hepatitis A vaccine, adult dosage |  | 
|   Concept | 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |  | 
|   Concept | 54 | adenovirus vaccine, type 4, live, oral |  | 
|   Concept | 55 | adenovirus vaccine, type 7, live, oral |  | 
|   Concept | 62 | human papilloma virus vaccine, quadrivalent |  | 
|   Concept | 66 | Lyme disease vaccine |  | 
|   Concept | 69 | parainfluenza-3 virus vaccine |  | 
|   Concept | 71 | respiratory syncytial virus immune globulin, intravenous |  | 
|   Concept | 74 | rotavirus, live, tetravalent vaccine |  | 
|   Concept | 75 | vaccinia (smallpox) vaccine |  | 
|   Concept | 76 | Staphylococcus bacteriophage lysate |  | 
|   Concept | 77 | tick-borne encephalitis vaccine |  | 
|   Concept | 78 | tularemia vaccine |  | 
|   Concept | 79 | vaccinia immune globulin |  | 
|   Concept | 80 | Venezuelan equine encephalitis, live, attenuated |  | 
|   Concept | 801 | AS03 Adjuvant |  | 
|   Concept | 81 | Venezuelan equine encephalitis, inactivated |  | 
|   Concept | 82 | adenovirus vaccine, unspecified formulation |  | 
|   Concept | 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |  | 
|   Concept | 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |  | 
|   Concept | 85 | hepatitis A vaccine, unspecified formulation |  | 
|   Concept | 86 | immune globulin, intramuscular |  | 
|   Concept | 87 | immune globulin, intravenous |  | 
|   Concept | 88 | influenza virus vaccine, unspecified formulation |  | 
|   Concept | 89 | poliovirus vaccine, unspecified formulation |  | 
|   Concept | 90 | rabies vaccine, unspecified formulation |  | 
|   Concept | 91 | typhoid vaccine, unspecified formulation |  | 
|   Concept | 92 | Venezuelan equine encephalitis vaccine, unspecified formulation |  | 
|   Concept | 93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |  | 
|   Concept | 94 | measles, mumps, rubella, and varicella virus vaccine |  | 
|   Concept | 95 | tuberculin skin test; old tuberculin, multipuncture device |  | 
|   Concept | 96 | tuberculin skin test; purified protein derivative solution, intradermal |  | 
|   Concept | 97 | tuberculin skin test; purified protein derivative, multipuncture device |  | 
|   Concept | 98 | tuberculin skin test; unspecified formulation |  | 
|   Concept | 998 | no vaccine administered |  | 
| Code | Display | Comments | 
|---|
|  01 | diphtheria, tetanus toxoids and pertussis vaccine |  | 
|  02 | trivalent poliovirus vaccine, live, oral |  | 
|  03 | measles, mumps and rubella virus vaccine |  | 
|  04 | measles and rubella virus vaccine |  | 
|  05 | measles virus vaccine |  | 
|  06 | rubella virus vaccine |  | 
|  07 | mumps virus vaccine |  | 
|  08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |  | 
|  09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
|  10 | poliovirus vaccine, inactivated |  | 
|  100 | pneumococcal conjugate vaccine, 7 valent |  | 
|  101 | typhoid Vi capsular polysaccharide vaccine |  | 
|  102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |  | 
|  103 | meningococcal C conjugate vaccine |  | 
|  104 | hepatitis A and hepatitis B vaccine |  | 
|  105 | vaccinia (smallpox) vaccine, diluted |  | 
|  106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |  | 
|  107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |  | 
|  108 | meningococcal ACWY vaccine, unspecified formulation |  | 
|  109 | pneumococcal vaccine, unspecified formulation |  | 
|  11 | pertussis vaccine |  | 
|  110 | DTaP-hepatitis B and poliovirus vaccine |  | 
|  111 | influenza virus vaccine, live, attenuated, for intranasal use |  | 
|  112 | tetanus toxoid, unspecified formulation |  | 
|  113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
|  114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |  | 
|  115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |  | 
|  116 | rotavirus, live, pentavalent vaccine |  | 
|  117 | varicella zoster immune globulin (Investigational New Drug) |  | 
|  118 | human papilloma virus vaccine, bivalent |  | 
|  119 | rotavirus, live, monovalent vaccine |  | 
|  12 | diphtheria antitoxin |  | 
|  120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
|  121 | zoster vaccine, live |  | 
|  122 | rotavirus vaccine, unspecified formulation |  | 
|  123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |  | 
|  125 | Novel Influenza-H1N1-09, live virus for nasal administration |  | 
|  126 | Novel influenza-H1N1-09, preservative-free, injectable |  | 
|  127 | Novel influenza-H1N1-09, injectable |  | 
|  128 | Novel influenza-H1N1-09, all formulations |  | 
|  129 | Japanese Encephalitis vaccine, unspecified formulation |  | 
|  13 | tetanus immune globulin |  | 
|  130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |  | 
|  131 | Historical record of a typhus vaccination |  | 
|  132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |  | 
|  133 | pneumococcal conjugate vaccine, 13 valent |  | 
|  134 | Japanese Encephalitis vaccine for intramuscular administration |  | 
|  135 | influenza, high dose seasonal, preservative-free |  | 
|  136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |  | 
|  137 | HPV, unspecified formulation |  | 
|  138 | tetanus and diphtheria toxoids, not adsorbed, for adult use |  | 
|  139 | Td(adult) unspecified formulation |  | 
|  14 | immune globulin, unspecified formulation |  | 
|  140 | Influenza, seasonal, injectable, preservative free |  | 
|  141 | Influenza, seasonal, injectable |  | 
|  142 | tetanus toxoid, not adsorbed |  | 
|  143 | Adenovirus, type 4 and type 7, live, oral |  | 
|  144 | seasonal influenza, intradermal, preservative free |  | 
|  147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |  | 
|  148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |  | 
|  149 | influenza, live, intranasal, quadrivalent |  | 
|  15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |  | 
|  150 | Influenza, injectable, quadrivalent, preservative free |  | 
|  151 | influenza nasal, unspecified formulation |  | 
|  152 | Pneumococcal Conjugate, unspecified formulation |  | 
|  153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free |  | 
|  155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |  | 
|  156 | Rho(D) Immune globulin- IV or IM |  | 
|  157 | Rho(D) Immune globulin - IM |  | 
|  158 | influenza, injectable, quadrivalent, contains preservative |  | 
|  159 | Rho(D) Unspecified formulation |  | 
|  16 | influenza virus vaccine, whole virus |  | 
|  160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |  | 
|  161 | Influenza, injectable,quadrivalent, preservative free, pediatric |  | 
|  162 | meningococcal B vaccine, fully recombinant |  | 
|  163 | meningococcal B vaccine, recombinant, OMV, adjuvanted |  | 
|  164 | meningococcal B, unspecified formulation |  | 
|  165 | Human Papillomavirus 9-valent vaccine |  | 
|  166 | influenza, intradermal, quadrivalent, preservative free, injectable |  | 
|  167 | meningococcal vaccine of unknown formulation and unknown serogroups |  | 
|  168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |  | 
|  169 | Hep A, live attenuated-IM |  | 
|  17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |  | 
|  170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
|  171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |  | 
|  172 | cholera, WC-rBS |  | 
|  173 | cholera, BivWC |  | 
|  174 | cholera, live attenuated |  | 
|  175 | Human Rabies vaccine from human diploid cell culture |  | 
|  176 | Human rabies vaccine from Chicken fibroblast culture |  | 
|  177 | pneumococcal conjugate vaccine, 10 valent |  | 
|  178 | Non-US bivalent oral polio vaccine (types 1 and 3) |  | 
|  179 | Non-US monovalent oral polio vaccine, unspecified formulation |  | 
|  18 | rabies vaccine, for intramuscular injection RETIRED CODE |  | 
|  180 | tetanus immune globulin |  | 
|  181 | anthrax immune globulin |  | 
|  182 | Oral Polio Vaccine, Unspecified formulation |  | 
|  183 | Yellow fever vaccine alternative formulation |  | 
|  184 | Yellow fever vaccine, unspecified formulation |  | 
|  185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |  | 
|  186 | Influenza, injectable, Madin Darby Canine Kidney,  quadrivalent with preservative |  | 
|  187 | zoster vaccine recombinant |  | 
|  188 | zoster vaccine, unspecified formulation |  | 
|  189 | Hepatitis B vaccine (recombinant), CpG adjuvanted |  | 
|  19 | Bacillus Calmette-Guerin vaccine |  | 
|  20 | diphtheria, tetanus toxoids and acellular pertussis vaccine |  | 
|  21 | varicella virus vaccine |  | 
|  22 | DTP-Haemophilus influenzae type b conjugate vaccine |  | 
|  23 | plague vaccine |  | 
|  24 | anthrax vaccine |  | 
|  25 | typhoid vaccine, live, oral |  | 
|  26 | cholera vaccine, unspecified formulation |  | 
|  27 | botulinum antitoxin |  | 
|  28 | diphtheria and tetanus toxoids, adsorbed for pediatric use |  | 
|  29 | cytomegalovirus immune globulin, intravenous |  | 
|  30 | hepatitis B immune globulin |  | 
|  31 | hepatitis A vaccine, pediatric dosage, unspecified formulation |  | 
|  32 | meningococcal polysaccharide vaccine (MPSV4) |  | 
|  33 | pneumococcal polysaccharide vaccine, 23 valent |  | 
|  34 | rabies immune globulin |  | 
|  35 | tetanus toxoid, adsorbed |  | 
|  36 | varicella zoster immune globulin |  | 
|  37 | yellow fever vaccine |  | 
|  38 | rubella and mumps virus vaccine |  | 
|  39 | Japanese Encephalitis Vaccine SC |  | 
|  40 | rabies vaccine, for intradermal injection |  | 
|  41 | typhoid vaccine, parenteral, other than acetone-killed, dried |  | 
|  42 | hepatitis B vaccine, adolescent/high risk infant dosage |  | 
|  43 | hepatitis B vaccine, adult dosage |  | 
|  44 | hepatitis B vaccine, dialysis patient dosage |  | 
|  45 | hepatitis B vaccine, unspecified formulation |  | 
|  46 | Haemophilus influenzae type b vaccine, PRP-D conjugate |  | 
|  47 | Haemophilus influenzae type b vaccine, HbOC conjugate |  | 
|  48 | Haemophilus influenzae type b vaccine, PRP-T conjugate |  | 
|  49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |  | 
|  50 | DTaP-Haemophilus influenzae type b conjugate vaccine |  | 
|  51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |  | 
|  52 | hepatitis A vaccine, adult dosage |  | 
|  53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |  | 
|  54 | adenovirus vaccine, type 4, live, oral |  | 
|  55 | adenovirus vaccine, type 7, live, oral |  | 
|  62 | human papilloma virus vaccine, quadrivalent |  | 
|  66 | Lyme disease vaccine |  | 
|  69 | parainfluenza-3 virus vaccine |  | 
|  71 | respiratory syncytial virus immune globulin, intravenous |  | 
|  74 | rotavirus, live, tetravalent vaccine |  | 
|  75 | vaccinia (smallpox) vaccine |  | 
|  76 | Staphylococcus bacteriophage lysate |  | 
|  77 | tick-borne encephalitis vaccine |  | 
|  78 | tularemia vaccine |  | 
|  79 | vaccinia immune globulin |  | 
|  80 | Venezuelan equine encephalitis, live, attenuated |  | 
|  801 | AS03 Adjuvant |  | 
|  81 | Venezuelan equine encephalitis, inactivated |  | 
|  82 | adenovirus vaccine, unspecified formulation |  | 
|  83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |  | 
|  84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |  | 
|  85 | hepatitis A vaccine, unspecified formulation |  | 
|  86 | immune globulin, intramuscular |  | 
|  87 | immune globulin, intravenous |  | 
|  88 | influenza virus vaccine, unspecified formulation |  | 
|  89 | poliovirus vaccine, unspecified formulation |  | 
|  90 | rabies vaccine, unspecified formulation |  | 
|  91 | typhoid vaccine, unspecified formulation |  | 
|  92 | Venezuelan equine encephalitis vaccine, unspecified formulation |  | 
|  93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |  | 
|  94 | measles, mumps, rubella, and varicella virus vaccine |  | 
|  95 | tuberculin skin test; old tuberculin, multipuncture device |  | 
|  96 | tuberculin skin test; purified protein derivative solution, intradermal |  | 
|  97 | tuberculin skin test; purified protein derivative, multipuncture device |  | 
|  98 | tuberculin skin test; unspecified formulation |  | 
|  998 | no vaccine administered |  |